Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Among authors: cecere sc. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Testicular and testicular adnexa tumors in the elderly.
Gigantino V, La Mantia E, Franco R, Cecere S, Rossetti S, Di Napoli M, Pisano C, Berretta M, Galzerano A, Botti G, Pignata S, Facchini G. Gigantino V, et al. Anticancer Drugs. 2013 Mar;24(3):228-36. doi: 10.1097/CAD.0b013e32835a3598. Anticancer Drugs. 2013. PMID: 23059385 Review.
Multidisciplinary treatment of early stage endometrial cancer.
Cecere SC, Pisano C, Bamias A, Di Napoli M, Rossetti S, Facchini G, Tambaro R, Pignata S. Cecere SC, et al. Anticancer Agents Med Chem. 2013 Jul 1;13(6):861-71. doi: 10.2174/18715206113139990111. Anticancer Agents Med Chem. 2013. PMID: 23194422
Intravesical chemo-immunotherapy in non muscle invasive bladder cancer.
Leopardo D, Cecere SC, Di Napoli M, Cavaliere C, Pisano C, Striano S, Marra L, Menna L, Claudio L, Perdonà S, Setola S, Berretta M, Franco R, Tambaro R, Pignata S, Facchini G. Leopardo D, et al. Among authors: cecere sc. Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2145-58. Eur Rev Med Pharmacol Sci. 2013. PMID: 23893180 Free article. Review.
New biological treatments for gynecological tumors: focus on angiogenesis.
Daniele G, Di Maio M, Piccirillo MC, Giordano P, Capuano I, Cecere SC, Bryce JC, Pignata S, Perrone F. Daniele G, et al. Among authors: cecere sc. Expert Opin Biol Ther. 2014 Mar;14(3):337-46. doi: 10.1517/14712598.2014.873401. Epub 2014 Jan 6. Expert Opin Biol Ther. 2014. PMID: 24387684 Review.
Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).
Esposito F, Cecere SC, Magazzino F, Katsaros D, Ottaiano A, Gadducci A, Pisano C, Scalone S, Rabaiotti E, Salutari V, Cormio G, Canuto EM, Greggi S, Savarese A, Marinaccio M, Scollo P, Santeufemia DA, Sacco C, Facchini G, Pignata S. Esposito F, et al. Among authors: cecere sc. Oncology. 2014;86(5-6):351-8. doi: 10.1159/000358730. Epub 2014 Jun 12. Oncology. 2014. PMID: 24942520
Ovarian cancer standard of care: are there real alternatives?
Della Pepa C, Tonini G, Pisano C, Di Napoli M, Cecere SC, Tambaro R, Facchini G, Pignata S. Della Pepa C, et al. Among authors: cecere sc. Chin J Cancer. 2015 Jan;34(1):17-27. doi: 10.5732/cjc.014.10274. Chin J Cancer. 2015. PMID: 25556615 Free PMC article. Review.
70 results